Celldex Therapeutics buy Morgan Stanley
Start price
09.05.25
/
50%
€16.30
Target price
09.05.26
€38.34
Performance (%)
28.83%
Price
02.02.26
€20.60
Summary
This prediction is currently active. The prediction currently has a performance of 28.83%. This prediction currently runs until 09.05.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | -4.630% | -4.630% |
| iShares Core DAX® | -0.436% | 1.181% |
| iShares Nasdaq 100 | 0.854% | 1.475% |
| iShares Nikkei 225® | 2.652% | 6.401% |
| iShares S&P 500 | 1.190% | 1.169% |
Comments by Morgan_Stanley for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its price target lowered by analysts at Morgan Stanley from $46.00 to $43.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Morgan_Stanley for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€18.40
20.03.25
20.03.25
€42.18
20.03.26
20.03.26
14.13%
02.02.26
02.02.26
